186 related articles for article (PubMed ID: 20037289)
1. [Mechanism of immunotherapy enhancement in cancer therapy by hyperthermia].
Takeda T; Miyazawa K; Takeda T; Takeda H; Hasegawa T; Takeda Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1955-7. PubMed ID: 20037289
[TBL] [Abstract][Full Text] [Related]
2. [Successful immunotherapy combined with hyperthermia therapy for cancer patients].
Takeda T; Dong X; Takeda H; Haba A; Takeda Y
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1739-41. PubMed ID: 17212092
[TBL] [Abstract][Full Text] [Related]
3. [Multidisciplinary therapy for 984 cancer patients--hyperthermic immunotherapy].
Takeda T; Miyazawa K; Takeda T; Takeda H; Takeda Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2243-5. PubMed ID: 21224535
[TBL] [Abstract][Full Text] [Related]
4. [Effects of intratumoral injection therapy of dendritic cells combined with hyperthermia for cancer patients].
Takeda T; Dong X; Takeda H; Haba A; Takeda Y
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1905-7. PubMed ID: 18219848
[TBL] [Abstract][Full Text] [Related]
5. Role of whole-body hyperthermia in the treatment of neoplastic disease: its current status and future prospects.
Robins HI
Cancer Res; 1984 Oct; 44(10 Suppl):4878s-4883s. PubMed ID: 6467241
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
[TBL] [Abstract][Full Text] [Related]
7. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.
Shen RN; Lu L; Kaiser HE; Broxmeyer HE
In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711
[TBL] [Abstract][Full Text] [Related]
8. Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma.
Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H
J Biosci Bioeng; 2005 Jul; 100(1):112-5. PubMed ID: 16233860
[TBL] [Abstract][Full Text] [Related]
9. The effect of radiofrequency hyperthermia and chemotherapy upon human neoplasms when used with adjuvant metronidazole.
Falk RE; Moffat FL; Calhoun K; Dreznik Z; Makowka L; Ambus U; Langer J; Howard V; Rotstein L; Falk JA
Surg Gynecol Obstet; 1983 Dec; 157(6):505-12. PubMed ID: 6648770
[TBL] [Abstract][Full Text] [Related]
10. Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity.
Mukhopadhaya A; Mendecki J; Dong X; Liu L; Kalnicki S; Garg M; Alfieri A; Guha C
Cancer Res; 2007 Aug; 67(16):7798-806. PubMed ID: 17699785
[TBL] [Abstract][Full Text] [Related]
11. [Hyperthermic immuno-cellular therapy-basic and clinical study].
Takeda T; Fukunaga K; Miyazawa K; Takahashi T; Takeda H; Takeda Y; Tanigawa K; Morisaki T; Yamamoto I; Hasegawa T
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2244-6. PubMed ID: 19106584
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy with hyperthermia for advanced or recurrent breast cancer patients in whom standard therapy showed no effect or was refused].
Takeda T; Takeda T; Kobayashi S; Takeda H
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1766-9. PubMed ID: 23267880
[TBL] [Abstract][Full Text] [Related]
13. [Addition of hyperthermia. Heat potentiates cancer therapy].
Hegewisch-Becker S; Hossfeld DK
MMW Fortschr Med; 2001 Jun; 143(25):28-32. PubMed ID: 11468993
[TBL] [Abstract][Full Text] [Related]
14. [Hyperthermia in combination with radiotherapy].
van der Zee J; van Rhoon GC; Haveman J; González González D
Ned Tijdschr Geneeskd; 1999 Jan; 143(2):76-80. PubMed ID: 10086108
[TBL] [Abstract][Full Text] [Related]
15. [Hyperthermic immunotherapy was effective in 3 CR cases as the standard treatments had no effects or could not be enforced].
Takeda H; Takeda T; Kobayashi S; Takeda T
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1939-41. PubMed ID: 22202245
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of the combined use of radiation therapy and hyperthermia].
Matsuda T; Tanaka Y; Takeshita N; Ishiwata J; Awane Y
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1508-14. PubMed ID: 3592696
[TBL] [Abstract][Full Text] [Related]
17. [20 years' experience in the use of local hyperthermia in the treatment of inoperable cancer of the esophagus].
Kochegarov AA; Muratkhodzhaev NK; Alimnazarov ShA; Bekirov ShA
Vopr Onkol; 1991; 37(7-8):856-60. PubMed ID: 1842643
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy and hyperthermia for the treatment of patients with advanced or recurrent colorectal cancer].
Takeda T; Akita H; Takeda T; Nakamura K; Kobayashi S; Takeda H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1606-8. PubMed ID: 24393863
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy: stress proteins and hyperthermia.
Manjili MH; Wang XY; Park J; Macdonald IJ; Li Y; Van Schie RC; Subjeck JR
Int J Hyperthermia; 2002; 18(6):506-20. PubMed ID: 12537751
[TBL] [Abstract][Full Text] [Related]
20. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
